7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of liver cancer
US2017253672A1
Removal of monomeric targets
US2017247454A1
Anti-pd1 antibodies and methods of use
US2016176899A1
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
US2016194350A1
3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
US2016122344A1
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
US2017227544A1
Methods for personalizing patient cancer therapy with an mdm2 antagonist
CN106573910A
Redox indicators
CN106574270A
Polypeptide expression systems
CN106456556A
New pharmaceutical composition comprising non-ionic surfactants
CN106459191A
Method for selecting antibodies with modified FcRn interaction
US2015211073A1
MRNA-based gene expression for personalizing patient cancer therapy with an MDM2 antagonist
US2015376166A1
Inhibitors of bruton's tyrosine kinase
US2016024055A1
Dimeric compounds
US2015329565A1
Substituted triazole boronic acid compounds
US2016272626A1
Pyrazine derivatives
CN106443016A
Method for the detection of a binding partner of a multispecific binder
US2015031715A1
Integrin antagonist conjugates for targeted delivery to cells expressing VLA-4
US2013109665A1
Pyrazine derivatives
CN105367577A
Pyrazolo[1,5A]Pyrimidine Derivatives As Irak4 Modulators
